CRISPLD1 Human Pre-designed siRNA Set A contains three designed siRNAs for CRISPLD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRISPLD2 Human Pre-designed siRNA Set A contains three designed siRNAs for CRISPLD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Crizotinib-d9 hydrochloride is deuterated labeled Crizotinib hydrochloride (HY-50878A). Crizotinib hydrochloride (PF-02341066 hydrochloride) is an orally bioavailable, selective, and ATP-competitive dual ALK and c-Met inhibitor with IC50s of 20 and 8 nM, respectively. Crizotinib hydrochloride (PF-02341066 hydrochloride) inhibits tyrosine phosphorylation of NPM-ALK and tyrosine phosphorylation of c-Met with IC50s of 24 and 11 nM in cell-based […]

CRK Human Pre-designed siRNA Set A contains three designed siRNAs for CRK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Crk Mouse Pre-designed siRNA Set A contains three designed siRNAs for Crk gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRKL Human Pre-designed siRNA Set A contains three designed siRNAs for CRKL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRLF1 Human Pre-designed siRNA Set A contains three designed siRNAs for CRLF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRLF2 Human Pre-designed siRNA Set A contains three designed siRNAs for CRLF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRLF3 Human Pre-designed siRNA Set A contains three designed siRNAs for CRLF3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRLS1 Human Pre-designed siRNA Set A contains three designed siRNAs for CRLS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRMP1 Human Pre-designed siRNA Set A contains three designed siRNAs for CRMP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRN04894 (compound 17h) is an orally active MC2R antagonist that demonstrates in vivo efficacy in rat model of adrenocorticotropic hormone (ACTH)-stimulated corticosterone secretion[1]. CRN04894 binds to human or rat MC2R with KB values of 0.34 nM and 0.23 nM, respsectively[1].

CRNKL1 Human Pre-designed siRNA Set A contains three designed siRNAs for CRNKL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Crocapeptin C is a cyclic depsipeptide that can be extrated from Melittangium boletus. Crocapeptin C exhibits potent inhibitory activity against chymotrypsin with an IC50 value of 0.5 µM[1].

CROCC Human Pre-designed siRNA Set A contains three designed siRNAs for CROCC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cromolyn (sodium) (Standard) is the analytical standard of Cromolyn (sodium). This product is intended for research and analytical applications. Cromolyn sodium (Disodium Cromoglycate; FPL-670) is an antiallergic agent. Cromolyn sodium is a GSK-3β inhibitor with an IC50 of 2.0 μM.

CROT Human Pre-designed siRNA Set A contains three designed siRNAs for CROT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRP Human Pre-designed siRNA Set A contains three designed siRNAs for CRP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRPPA Human Pre-designed siRNA Set A contains three designed siRNAs for CRPPA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRSP-1 is short for calcitonin receptor-stimulating peptide-1. CRSP-1 inhibits osteoclast formation by inhibiting the formation and activity of multinucleated osteoclast[1].

CRT0066101 is a potent and orally active PKD inhibitor with IC50 values of 1 nM, 2.5 nM and 2 nM for PKD1, PKD2, and PKD3, respectively[1]. CRT0066101 is also a potent PIM2 inhibitor with an IC50 of ~135.7 nM. CRT0066101 has anticancer effects[2].

CRT0066101 is a potent and orally active PKD inhibitor with IC50 values of 1 nM, 2.5 nM and 2 nM for PKD1, PKD2, and PKD3, respectively[1]. CRT0066101 is also a potent PIM2 inhibitor with an IC50 of ~135.7 nM. CRT0066101 has anticancer effects[2].

CRTAC1 Human Pre-designed siRNA Set A contains three designed siRNAs for CRTAC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRTAM Human Pre-designed siRNA Set A contains three designed siRNAs for CRTAM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRTAP Human Pre-designed siRNA Set A contains three designed siRNAs for CRTAP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRTC1 Human Pre-designed siRNA Set A contains three designed siRNAs for CRTC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRTC2 Human Pre-designed siRNA Set A contains three designed siRNAs for CRTC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRTC3 Human Pre-designed siRNA Set A contains three designed siRNAs for CRTC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRTh2 antagonist 4 (compound 58) is an inhibitor (IC50: 212 nM) of TH2 lymphocyte (CRTH2 or DP2) receptor with high binding affinity (Ki= 37 nM). CRTh2 antagonist 4 can be used in the study of severe allergic diseases[1].

CRX Human Pre-designed siRNA Set A contains three designed siRNAs for CRX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRY1 Human Pre-designed siRNA Set A contains three designed siRNAs for CRY1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRY2 Human Pre-designed siRNA Set A contains three designed siRNAs for CRY2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRYAA Human Pre-designed siRNA Set A contains three designed siRNAs for CRYAA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRYAB Human Pre-designed siRNA Set A contains three designed siRNAs for CRYAB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CRYBA1 Human Pre-designed siRNA Set A contains three designed siRNAs for CRYBA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.